NEW YORK (Reuters Health) - Testing for genetic defects early in pregnancy through chorionic villus sampling, or CVS, does not appear to raise the risk of fetal loss. CVS involves using a needle to ...
Chorionic villus sampling is a prenatal diagnostic test performed for prenatal genetic testing involving a biopsy of placental tissue between 10 to 13 weeks gestation. The tissue harvested is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback